SEC Comment Letter for DarioHealth Corp. (DRIO) (CIK 0001533998) (DRIO) — Nov 28, 2018
DarioHealth Corp. (DRIO) (CIK 0001533998)
Date: Nov. 28, 2018 · CIK: 0001533998 · Accession: 0000000000-18-036452
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-228201
Letter
November 16, 2018 Zvi Ben David Chief Financial Officer DarioHealth Corp. 8 HaTokhen Street Caesarea Industrial Park 3088900, Israel Re:DarioHealth Corp. Registration Statement on Form S-3 Filed November 6, 2018 File No. 333-228201 Dear Mr. Ben David: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Eric Atallah at (202) 551-3663 with any questions. Sincerely, Division of Corporation Finance Office of Electronics and Machinery cc: Robert V. Condon III
Show Raw Text
November 16, 2018
Zvi Ben David
Chief Financial Officer
DarioHealth Corp.
8 HaTokhen Street
Caesarea Industrial Park 3088900, Israel
Re:DarioHealth Corp.
Registration Statement on Form S-3
Filed November 6, 2018
File No. 333-228201
Dear Mr. Ben David:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Eric Atallah at (202) 551-3663 with any questions.
Sincerely,
Division of Corporation Finance
Office of Electronics and Machinery
cc: Robert V. Condon III